• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sec61 阻断剂美拉诺菌素抑制抗原交叉呈递,而不依赖于内体到细胞质的输出。

Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export.

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.

Centre de Recherche, Institut Curie, 75005 Paris, France.

出版信息

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5910-E5919. doi: 10.1073/pnas.1705242114. Epub 2017 Jul 5.

DOI:10.1073/pnas.1705242114
PMID:28679634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5530691/
Abstract

Although antigen cross-presentation in dendritic cells (DCs) is critical to the initiation of most cytotoxic immune responses, the intracellular mechanisms and traffic pathways involved are still unclear. One of the most critical steps in this process, the export of internalized antigen to the cytosol, has been suggested to be mediated by Sec61. Sec61 is the channel that translocates signal peptide-bearing nascent polypeptides into the endoplasmic reticulum (ER), and it was also proposed to mediate protein retrotranslocation during ER-associated degradation (a process called ERAD). Here, we used a newly identified Sec61 blocker, mycolactone, to analyze Sec61's contribution to antigen cross-presentation, ERAD, and transport of internalized antigens into the cytosol. As shown previously in other cell types, mycolactone prevented protein import into the ER of DCs. Mycolactone-mediated Sec61 blockade also potently suppressed both antigen cross-presentation and direct presentation of synthetic peptides to CD8 T cells. In contrast, it did not affect protein export from the ER lumen or from endosomes into the cytosol, suggesting that the inhibition of cross-presentation was not related to either of these trafficking pathways. Proteomic profiling of mycolactone-exposed DCs showed that expression of mediators of antigen presentation, including MHC class I and β2 microglobulin, were highly susceptible to mycolactone treatment, indicating that Sec61 blockade affects antigen cross-presentation indirectly. Together, our data suggest that the defective translocation and subsequent degradation of Sec61 substrates is the cause of altered antigen cross-presentation in Sec61-blocked DCs.

摘要

虽然抗原交叉呈现在树突状细胞(DC)中对于大多数细胞毒性免疫反应的启动至关重要,但涉及的细胞内机制和运输途径仍不清楚。在这个过程中最关键的步骤之一,即将内化的抗原输出到细胞质中,据推测是由 Sec61 介导的。Sec61 是一种将带有信号肽的新生多肽易位到内质网(ER)中的通道,它也被提议在 ER 相关降解(称为 ERAD)过程中介导蛋白质逆行转运。在这里,我们使用新鉴定的 Sec61 阻断剂,mycolactone,来分析 Sec61 对抗原交叉呈递、ERAD 和内化抗原进入细胞质的运输的贡献。如先前在其他细胞类型中所示,mycolactone 阻止了蛋白质向 DC 的 ER 内的导入。mycolactone 介导的 Sec61 阻断还强烈抑制了抗原交叉呈递和合成肽对 CD8 T 细胞的直接呈递。相比之下,它不影响 ER 腔或内体中的蛋白质从 ER 腔或内体向细胞质的输出,表明抑制交叉呈递与这两种运输途径都无关。暴露于 mycolactone 的 DC 的蛋白质组学分析表明,抗原呈递的介质表达,包括 MHC 类 I 和β2 微球蛋白,高度易受 mycolactone 处理的影响,这表明 Sec61 阻断间接影响抗原交叉呈递。总之,我们的数据表明 Sec61 底物的转运和随后的降解缺陷是 Sec61 阻断的 DC 中改变抗原交叉呈递的原因。

相似文献

1
Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export.Sec61 阻断剂美拉诺菌素抑制抗原交叉呈递,而不依赖于内体到细胞质的输出。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5910-E5919. doi: 10.1073/pnas.1705242114. Epub 2017 Jul 5.
2
The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells.易位蛋白 Sec61 将内体中的抗原从细胞质中转运出来,进行交叉呈递给 CD8(+)T 细胞。
Immunity. 2015 May 19;42(5):850-63. doi: 10.1016/j.immuni.2015.04.008. Epub 2015 May 12.
3
Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.人树突状细胞对合成长肽的交叉呈递:一个依赖于内质网相关蛋白降解(ERAD)组分p97/VCP而非Sec61和/或Derlin-1的过程。
PLoS One. 2014 Feb 27;9(2):e89897. doi: 10.1371/journal.pone.0089897. eCollection 2014.
4
Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis.分枝杆菌内酯揭示了Sec61依赖性跨膜蛋白生物合成的底物驱动复杂性。
J Cell Sci. 2017 Apr 1;130(7):1307-1320. doi: 10.1242/jcs.198655. Epub 2017 Feb 20.
5
A Case for Sec61 Channel Involvement in ERAD.Sec61 通道参与 ERAD 的案例。
Trends Biochem Sci. 2017 Mar;42(3):171-179. doi: 10.1016/j.tibs.2016.10.005. Epub 2016 Dec 5.
6
Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone.关于分枝杆菌内酯对Sec61依赖性共翻译和翻译后易位的抑制作用的机制性见解。
J Cell Sci. 2016 Apr 1;129(7):1404-15. doi: 10.1242/jcs.182352. Epub 2016 Feb 11.
7
Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.生物化学和生物测定法分析 Mycolactone 介导的 Sec61 抑制作用
Methods Mol Biol. 2022;2387:163-181. doi: 10.1007/978-1-0716-1779-3_16.
8
Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature.蛋白质组学揭示了分枝菌酸介导的 Sec61 阻断的范围和独特的应激特征。
Mol Cell Proteomics. 2018 Sep;17(9):1750-1765. doi: 10.1074/mcp.RA118.000824. Epub 2018 Jun 18.
9
Mycolactone enhances the Ca2+ leak from endoplasmic reticulum by trapping Sec61 translocons in a Ca2+ permeable state.肌抑素通过将 Sec61 移位蛋白困在可通透钙离子的状态增强内质网钙离子泄漏。
Biochem J. 2021 Nov 26;478(22):4005-4024. doi: 10.1042/BCJ20210345.
10
Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.支原体内酯对Sec61的阻断:布鲁里溃疡病的核心机制。
Biol Cell. 2018 Nov;110(11):237-248. doi: 10.1111/boc.201800030. Epub 2018 Aug 14.

引用本文的文献

1
Potential of bacterial outer membrane vesicles in tumor vaccine: characteristics, advancements, and future directions.细菌外膜囊泡在肿瘤疫苗中的潜力:特性、进展及未来方向。
Essays Biochem. 2025 Mar 28;69(2):EBC20253004. doi: 10.1042/EBC20253004.
2
The toxin mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane to drive skin necrosis.毒素分枝杆菌内酯会导致内皮糖萼和血管基底膜发生依赖于Sec61的破坏性损失,从而引发皮肤坏死。
Elife. 2025 Feb 6;12:RP86931. doi: 10.7554/eLife.86931.
3
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells.内质网应激与肿瘤细胞顺铂耐药性相关的质量控制
Front Pharmacol. 2024 Jun 14;15:1419468. doi: 10.3389/fphar.2024.1419468. eCollection 2024.
4
Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere-Encapsulated Antigen and a Synthetic Long Peptide In Vitro.Sec22b 和 Stx4 耗竭对 PLGA 微球包封抗原和合成长肽的体外交叉呈递无主要影响。
J Immunol. 2023 Oct 15;211(8):1203-1215. doi: 10.4049/jimmunol.2200473.
5
Major histocompatibility complex class I assembly within endolysosomal pathways.主要组织相容性复合体 I 类分子在内体溶酶体途径中的组装。
Curr Opin Immunol. 2023 Oct;84:102356. doi: 10.1016/j.coi.2023.102356. Epub 2023 Jun 26.
6
From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.从细菌毒素到治疗剂:类鼻疽酮的意外命运。
Toxins (Basel). 2023 May 30;15(6):369. doi: 10.3390/toxins15060369.
7
Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells.穿孔素-2 是呈递交叉抗原的树突状细胞内吞逃逸的孔形成效应因子。
Science. 2023 Jun 23;380(6651):1258-1265. doi: 10.1126/science.adg8802. Epub 2023 Jun 22.
8
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?1 型经典树突状细胞交叉呈递的最新进展——胞质溶胶、空泡还是两者兼而有之?
Curr Opin Immunol. 2023 Aug;83:102350. doi: 10.1016/j.coi.2023.102350. Epub 2023 Jun 3.
9
Mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane: a new indirect mechanism driving tissue necrosis in infection.分枝杆菌内酯导致依赖Sec61的内皮糖萼和血管基底膜的破坏性丧失:感染中驱动组织坏死的一种新的间接机制。
bioRxiv. 2024 Oct 1:2023.02.21.529382. doi: 10.1101/2023.02.21.529382.
10
Pathways of MHC I cross-presentation of exogenous antigens.MHC I 类分子交叉呈递外源抗原的途径。
Semin Immunol. 2023 Mar;66:101729. doi: 10.1016/j.smim.2023.101729. Epub 2023 Feb 16.

本文引用的文献

1
Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis.分枝杆菌内酯揭示了Sec61依赖性跨膜蛋白生物合成的底物驱动复杂性。
J Cell Sci. 2017 Apr 1;130(7):1307-1320. doi: 10.1242/jcs.198655. Epub 2017 Feb 20.
2
Mycolactone subverts immunity by selectively blocking the Sec61 translocon.支原体内酯通过选择性阻断Sec61转运体来破坏免疫。
J Exp Med. 2016 Dec 12;213(13):2885-2896. doi: 10.1084/jem.20160662. Epub 2016 Nov 7.
3
Dendritic cell maturation and cross-presentation: timing matters!树突状细胞成熟与交叉呈递:时机至关重要!
Immunol Rev. 2016 Jul;272(1):97-108. doi: 10.1111/imr.12432.
4
Lipid peroxidation causes endosomal antigen release for cross-presentation.脂质过氧化导致内体抗原释放以进行交叉呈递。
Sci Rep. 2016 Feb 24;6:22064. doi: 10.1038/srep22064.
5
Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone.关于分枝杆菌内酯对Sec61依赖性共翻译和翻译后易位的抑制作用的机制性见解。
J Cell Sci. 2016 Apr 1;129(7):1404-15. doi: 10.1242/jcs.182352. Epub 2016 Feb 11.
6
Structure of the Sec61 channel opened by a signal sequence.由信号序列打开的Sec61通道的结构。
Science. 2016 Jan 1;351(6268):88-91. doi: 10.1126/science.aad4992.
7
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.靶向AAA型ATP酶p97作为一种通过破坏蛋白质稳态来治疗癌症的方法。
Cancer Cell. 2015 Nov 9;28(5):653-665. doi: 10.1016/j.ccell.2015.10.002.
8
2016 update of the PRIDE database and its related tools.PRIDE数据库及其相关工具的2016年更新。
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56. doi: 10.1093/nar/gkv1145. Epub 2015 Nov 2.
9
Inhibitors of Protein Translocation Across the ER Membrane.内质网膜蛋白转运抑制剂。
Traffic. 2015 Oct;16(10):1027-38. doi: 10.1111/tra.12308. Epub 2015 Jul 27.
10
Are ERAD components involved in cross-presentation?内质网相关降解(ERAD)组件是否参与交叉呈递?
Mol Immunol. 2015 Dec;68(2 Pt A):112-5. doi: 10.1016/j.molimm.2015.05.002. Epub 2015 May 23.